Soligenix (SNGX) Assets (2010 - 2026)
Soligenix's (SNGX) quarterly Assets came in at $6.9 million in Q1 2026, down 10.63% YoY from $7.7 million in Q1 2025, and down 25.04% on a QoQ basis from $9.2 million in Q4 2025.
Soligenix (SNGX) Assets (2010 - 2026) Analysis & Trends
Soligenix (SNGX) has 17 years of Assets data on file, last reported at $6.9 million in Q1 2026.
- Quarterly Assets fell 10.63% year-over-year to $6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.9 million (down 10.63% YoY) and the FY2025 annual result came in at $9.2 million, up 3.0% from the prior year.
- Assets eased to $6.9 million in Q1 2026, from $9.2 million in the prior quarter.
- In the past five years, Assets ranged from a high of $23.7 million in Q1 2022 to a low of $5.8 million in Q2 2025.
- A 5-year average of $11.9 million and a median of $10.5 million in 2024 frame the typical range for Assets.
- Annual changes were most pronounced in 2023 — Assets tumbled 53.11% — and 2025, when it climbed 7.8%.
- Tracing SNGX's Assets over 5 years: stood at $14.3 million in 2022, then sank by 31.39% to $9.8 million in 2023, then declined by 8.48% to $9.0 million in 2024, then grew by 3.0% to $9.2 million in 2025, then retreated by 25.04% to $6.9 million in 2026.
- The last three Assets figures came in at $6.9 million (Q1 2026), $9.2 million (Q4 2025), and $11.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 19.82 Bn |
| 10 | Soligenix | 6.38 Mn | 6.38 Mn | - | 10.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.50 Mn |
| Mar 31, 2026 | 6.92 Mn |
| Dec 31, 2025 | 9.24 Mn |
| Sep 30, 2025 | 11.29 Mn |
| Jun 30, 2025 | 5.76 Mn |
| Mar 31, 2025 | 7.75 Mn |
| Dec 31, 2024 | 8.97 Mn |
| Sep 30, 2024 | 10.48 Mn |
| Jun 30, 2024 | 9.87 Mn |
| Mar 31, 2024 | 8.06 Mn |
| Dec 31, 2023 | 9.80 Mn |
| Sep 30, 2023 | 11.30 Mn |
| Jun 30, 2023 | 13.83 Mn |
| Mar 31, 2023 | 11.10 Mn |
| Dec 31, 2022 | 14.28 Mn |
| Sep 30, 2022 | 17.95 Mn |
| Jun 30, 2022 | 21.31 Mn |
| Mar 31, 2022 | 23.67 Mn |
| Dec 31, 2021 | 26.87 Mn |
| Sep 30, 2021 | 29.72 Mn |